Neuroone Medical Technologies (NMTC) EBT Margin (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly EBT Margin came in at 101.68% in Q2 2026, down 1319.0% on a YoY basis from 8.34% in Q2 2025, and up 20.51% quarter-over-quarter from 127.92% in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) EBT Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported EBT Margin for 13 consecutive years, with 101.68% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 1319.0% year-over-year to 101.68%; the trailing twelve-month figure through Jun 2026 stood at 78.63% (up 187.0% YoY), and the FY2025 full-year result was 39.63%, up 31711.0% from the prior year.
- EBT Margin improved to 101.68% in Q2 2026 per NMTC's latest filing, from 127.92% in the prior quarter.
- Across five years, EBT Margin topped out at 54.53% in Q4 2024 and bottomed at 8610.96% in Q2 2022.
- Historically, EBT Margin has averaged 1381.14% across 5 years, with a median of 338.64% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBT Margin sank 124961 bps in 2022, then jumped 806028 bps in 2023.
- Over 5 years, EBT Margin stood at 1512.29% in 2022, then jumped by 77 bps to 342.14% in 2023, then soared by 116 bps to 54.53% in 2024, then plunged by 191 bps to 49.71% in 2025, then tumbled by 105 bps to 101.68% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 101.68%, 127.92%, and 49.71% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | -101.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -101.68% |
| Mar 31, 2026 | -127.92% |
| Dec 31, 2025 | -49.71% |
| Sep 30, 2025 | -59.08% |
| Jun 30, 2025 | -88.49% |
| Mar 31, 2025 | -163.76% |
| Dec 31, 2024 | 54.53% |
| Sep 30, 2024 | -1,230.55% |
| Jun 30, 2024 | -335.14% |
| Mar 31, 2024 | -207.30% |
| Dec 31, 2023 | -342.14% |
| Sep 30, 2023 | -422.65% |
| Jun 30, 2023 | -550.68% |
| Mar 31, 2023 | -755.69% |
| Dec 31, 2022 | -1,512.29% |
| Sep 30, 2022 | -1,997.94% |
| Jun 30, 2022 | -8,610.96% |
| Mar 31, 2022 | -8,359.03% |
| Dec 31, 2021 | -8,318.94% |
| Sep 30, 2021 | -5,470.30% |